See also this year's filing and all EDGAR filings for this company.
PDF Report 0001343009_2015_CNBX_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001343009, CNBX Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 112,757 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,465 |
| 3 | remainder_Assets | 4,409,899 |
| 4 | LiabilitiesCurrent | 74,140 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 40,435 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 175,697 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -53,873 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,524,121 |
| 1 | Liabilities | 74,140 |
| 2 | Expenses | 216,132 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 4,449,981 |
| 5 | NetIncome | -270,005 |
| 6 | ComprehensiveNetIncome | -270,005 |
| 7 | BaseVar | 2,434,133 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.10 |
| 9 | EconomicCapitalRatio | 4.47 |
Edgar->Model Mapping
Feature Distribution
